Message from the TopManagement Group Philosophy KAITEKI Charter of Corporate Behavior Group Motto Corporate Message Corporate Identity Corporate Governance Risk Management Compliance Global Network Corporate Brochure Medium-TermManagement Plan Corporate Profile Group Outline Business Domains Leadership Corporate Organization Major Subsidiaries and Affiliates History
Value Creation Approach KAITEKI Health and Productivity Management Message from the CHO KAITEKI REPORT 2019 KAITEKI Materiality Assessment Download KAITEKIReport Achievement Evaluation by Outside Parties
Message from the President Message from the CFO TSE Filings IR News Disclosure Policy IR Library Financial Results Operating Summaries Analysts Meeting Materials Integrated report Stock and Bond Information Overview Dividend Shareholders Meeting Articles of Incorporation Ratings and Bonds Chart Medium-TermManagement Plan Financial Data To Our Individual Investors IR Calendar MCHC in Numbers
Message from the CIO R&D Philosophy Research and Development Management Core Technology Achievement Evaluation by Outside Parties
Message from the CSO Materiality Assessment Materiality and SDGs The MOS Indices Reporting Based on the Charter of Corporate Behavior Awareness and Responsibility (KAITEKI Promotion Framework) Legal Compliance and Fairness, Equitability, and Integrity Valuing Stakeholders Respecting Human Rights Employment and Labor Enhancing Employee Satisfaction Supporting the Success of Diverse Human Resources Work-Life Balance Employee Capability Development Employee Health Management Occupational Health and Safety Relationship between Employers and Employees Environment and Safety Process Safety and Disaster Prevention Reducing Greenhouse Gas Emissions Reducing Emissions of Substances that Impact the Environment Reducing Waste Preserving Water Resources Resource Conservation Measures Preserving Biodiversity Managing and Providing Information on Chemical Substances Disclosure and Good Using Practice of Technologies Related to Genetically Modified Organisms Product Stewardship Fair Business Practices Anti-Bribery and Corruption Anti-Trust and Unfair Trade Measures against Anti-Social Influences Customer Satisfaction Information Management Community Involvement Shared Standards Policy on Sustainability Non-Financial Data Sheet Fiscal 2018 data sheet(PDF:1.22MB) Evaluation by Outside Parties HOME> About the Group> Group Outline> Life Science Institute, Inc. Life Science Institute, Inc. Outline As of March 31, 2019 Company name Life Science Institute, Inc. Click here to view the corporate website Head office THE KAITEKI Building, 13‐4 Uchikanda 1‐chome, Chiyoda‐ku, Tokyo 101‐0047 Date of establishment April 1, 2014 Paid-in capital 3.0 billion yen Line of business (consolidated) Health and medical ICT, advanced medication, and drug development & manufacturing solutions Sales revenue（Consolidated） 131.8 billion（FY2018） Employees (Consolidated) 4,752 About Mitsubishi Chemical Holdings Corporation Corporate Profile Group Outline Leadership Global Network KAITEKI Report We combined information about progress and performance in management targeting the achievement of KAITEKI and published the KAITEKI Report. Find out more KAITEKI About the KAITEKI concept and KAITEKI Management that Mitsubishi Chemical Holdings Corporation aims to put into practice. MCHC in Numbers Mitsubishi Chemical Holdings Corporation are explained in an easily understandable and compact manner.
KAITEKI
